Back

Transcatheter versus surgical aortic valve replacement in patients with prior cardiac surgery in the randomized PARTNER 2A Trial

28 August 2018 (09:06 - 09:24)
Organised by:
Congress Presentation Part of: The moving target of strategy selection in severe aortic stenosis Intervention ESC Premium Access ESC Congress 2018

About the speaker

Photo
Doctor Bjorn Redfors

Sahlgrenska Academy - University of Gothenburg, Gothenburg (Sweden)

3 More presentations in this session

Presentation thumbnail
Heart Team decision making in severe aortic stenosis - State of the art
Professor J. Chambers (London, GB)
Slides Video
Presentation thumbnail
Transcatheter aortic valve implantation futility risk model: insight on a national registry
Doctor O. Zusman (Tel Aviv, IL)
Abstract Slides Video
Presentation thumbnail
In which patients does surgical aortic valve replacement remain the standard?
Professor M. Borger (Leipzig, DE)
Slides Video

Access the full session

Session thumbnail
The moving target of strategy selection in severe aortic stenosis

The Event

Event poster

ESC Congress 2018

28 August 2018 09:06 CET
You may be interested in
thumbnail
Congress Presentation
Contemporary trends and outcomes of percutaneous vs. surgical aortic valve replacement in cancer patients.
1 September 2019
thumbnail
Congress Session
ESC Paul Hugenholtz Lecture in Innovation
25 August 2023
thumbnail
Congress Presentation
Aortic stenosis and the evolution of cardiac damage after transcatheter aortic valve replacement.
30 August 2024
thumbnail
Congress Presentation
Comparative analysis of device performance and pacemaker implantation rates in supra-Annular and intra-annular TAVR valves in patients with small aortic annulus
18 May 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources